These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 1692708)
21. Rat urinary bladder denuded of urothelium. An in vivo model for the epithelial-stromal interactions in carcinogenesis. Samma S; Homma Y; Oyasu R Am J Pathol; 1987 Aug; 128(2):328-37. PubMed ID: 3303952 [TBL] [Abstract][Full Text] [Related]
22. Effects of 12-O-tetradecanoylphorbol-13-acetate on carcinogenesis in the heterotopically transplanted rat urinary bladder. Izumi K; Shibata M; Togei K; Akagi A; Otsuka H; Jacobs JB; Ozono S; Miyata Y; Oyasu R Gan; 1984 Sep; 75(9):756-62. PubMed ID: 6500231 [TBL] [Abstract][Full Text] [Related]
23. H-ras p21 and peanut lectin immunoreactivity of hyperplastic, preneoplastic and neoplastic urinary bladder lesions in rats. Ward JM; Hagiwara A; Tsuda H; Tatematsu M; Ito N Jpn J Cancer Res; 1988 Feb; 79(2):152-5. PubMed ID: 3130347 [TBL] [Abstract][Full Text] [Related]
24. Effects of treatment with N-methyl-N-nitrosourea, artificial sweeteners, and cyclophosphamide on adult rat urinary bladder in vitro. Norman JT; Howlett AR; Spacey GD; Hodges GM Lab Invest; 1987 Oct; 57(4):429-38. PubMed ID: 2444767 [TBL] [Abstract][Full Text] [Related]
25. Cell cycle dependence of N-methyl-N-nitrosourea-induced tumour development in the proliferating, partially resected rat urinary bladder. Kunze E; Graewe T; Scherber S; Weber J; Gellhar P Br J Exp Pathol; 1989 Apr; 70(2):125-42. PubMed ID: 2730838 [TBL] [Abstract][Full Text] [Related]
26. [So-called "superficial" bladder tumors. Which classification in 2003? Part 2: Flat urothelial lesions]. Sibony M; Billerey C Ann Pathol; 2003 Feb; 23(1):35-45. PubMed ID: 12743498 [TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical interpretation of early epithelial disorders of pyriform sinus. Murakami Y; Saito Y Ann Otol Rhinol Laryngol; 1990 Oct; 99(10 Pt 1):782-8. PubMed ID: 1699466 [TBL] [Abstract][Full Text] [Related]
28. Immunohistochemistry of cytokeratin proteins in squamous and transitional cell lesions of the urinary tract. Tungekar MF; Gatter KC; Al-Adnani MS J Clin Pathol; 1988 Dec; 41(12):1288-96. PubMed ID: 2465317 [TBL] [Abstract][Full Text] [Related]
29. Altered expression of CKs 14/20 is an early event in a rat model of multistep bladder carcinogenesis. Gil da Costa RM; Oliveira PA; Vasconcelos-Nóbrega C; Arantes-Rodrigues R; Pinto-Leite R; Colaço AA; de la Cruz LF; Lopes C Int J Exp Pathol; 2015 Oct; 96(5):319-25. PubMed ID: 26515584 [TBL] [Abstract][Full Text] [Related]
30. Differential expression of cytokeratin 14 and 18 in bladder cancer tumorigenesis. Li YP; Jia XP; Jiang YQ; Wang W; Wang YL; Wang XL; Guo YX Exp Biol Med (Maywood); 2018 Feb; 243(4):344-349. PubMed ID: 29350066 [TBL] [Abstract][Full Text] [Related]
31. Utility of a comprehensive immunohistochemical panel in the differential diagnosis of spindle cell lesions of the urinary bladder. Westfall DE; Folpe AL; Paner GP; Oliva E; Goldstein L; Alsabeh R; Gown AM; Amin MB Am J Surg Pathol; 2009 Jan; 33(1):99-105. PubMed ID: 18941404 [TBL] [Abstract][Full Text] [Related]
32. Cytokeratin 20: a new marker for early detection of bladder cell carcinoma? Buchumensky V; Klein A; Zemer R; Kessler OJ; Zimlichman S; Nissenkorn I J Urol; 1998 Dec; 160(6 Pt 1):1971-4. PubMed ID: 9817302 [TBL] [Abstract][Full Text] [Related]
33. Bracken fern-induced bladder tumors in guinea pigs. A model for human neoplasia. Bringuier PP; Piaton E; Berger N; Debruyne F; Perrin P; Schalken J; Devonec M Am J Pathol; 1995 Sep; 147(3):858-68. PubMed ID: 7545876 [TBL] [Abstract][Full Text] [Related]
34. [Cytokeratins and transitional epithelium of the bladder. Particular distribution of cytokeratins]. Fetissof F; Serres G; Haillot O Arch Anat Cytol Pathol; 1990; 38(4):159-62. PubMed ID: 1699500 [TBL] [Abstract][Full Text] [Related]
35. Cytokeratin expression during neoplastic progression of human transitional cell carcinomas as detected by a monoclonal and a polyclonal antibody. Ramaekers F; Huysmans A; Moesker O; Schaart G; Herman C; Vooijs P Lab Invest; 1985 Jan; 52(1):31-8. PubMed ID: 2578201 [TBL] [Abstract][Full Text] [Related]
36. [Cytokeratins in inverted papillomas of the urinary bladder. (Part 1.)]. Stosiek P; Kasper M; Seidenschnur A; Goertchen R Pathologe; 1993 Dec; 14(6):330-3. PubMed ID: 7510066 [TBL] [Abstract][Full Text] [Related]
37. Susceptibility of urothelium to neoplastic cellular implantation. Weldon TE; Soloway MS Urology; 1975 Jun; 5(6):824-7. PubMed ID: 1136099 [TBL] [Abstract][Full Text] [Related]
38. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019 [TBL] [Abstract][Full Text] [Related]
39. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases. Guo CC; Fine SW; Epstein JI Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332 [TBL] [Abstract][Full Text] [Related]
40. Urothelial carcinogenesis in the urinary bladder of rats treated with naveglitazar, a gamma-dominant PPAR alpha/gamma agonist: lack of evidence for urolithiasis as an inciting event. Long GG; Reynolds VL; Lopez-Martinez A; Ryan TE; White SL; Eldridge SR Toxicol Pathol; 2008 Feb; 36(2):218-31. PubMed ID: 18474944 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]